Financhill
Buy
74

CIB Quote, Financials, Valuation and Earnings

Last price:
$64.20
Seasonality move :
4.59%
Day range:
$63.63 - $64.78
52-week range:
$31.19 - $65.73
Dividend yield:
9.64%
P/E ratio:
16.47x
P/S ratio:
1.47x
P/B ratio:
3.02x
Volume:
131K
Avg. volume:
311K
1-year change:
99.29%
Market cap:
$15.4B
Revenue:
$10.9B
EPS (TTM):
$3.91

Earnings Data

Next earnings date for CIB
Feb 11
2026
Most recent earnings per share
$1.19
Missed by $0.61
(Nov 6/2025)
Consensus Estimate
$1.80
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CIB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/11/2026 Q4 $2.1B -- -- $1.98 --
11/06/2025 Q3 $1.9B $2.8B $1.19 $1.80 -$0.61
08/06/2025 Q2 $1.7B $2.6B $0.95 $1.65 -$0.70
05/05/2025 Q1 $1.7B $2.6B $0.92 $1.60 -$0.68
02/19/2025 Q4 $1.7B $2.6B $0.85 $1.39 -$0.54
11/07/2024 Q3 $1.6B $2.7B $0.82 $1.42 -$0.61
08/08/2024 Q2 $1.7B $2.9B $0.82 $1.48 -$0.66
05/09/2024 Q1 $1.8B $2.8B $0.94 $1.45 -$0.50
02/20/2024 Q4 $1.8B $2.9B $0.79 $1.38 -$0.59
11/08/2023 Q3 -- $2.9B $0.82 -- --
08/10/2023 Q2 -- $2.7B $0.74 -- --
05/10/2023 Q1 -- $2.5B $0.80 -- --
02/23/2023 Q4 -- $2.1B $0.76 -- --
11/09/2022 Q3 -- $2B $0.83 -- --
08/02/2022 Q2 -- $1.9B $1.01 -- --
05/11/2022 Q1 -- $1.7B $0.98 -- --
02/22/2022 Q4 -- $1.6B $0.83 -- --
11/03/2021 Q3 -- $1.5B $0.55 -- --
08/04/2021 Q2 -- $1.5B $0.70 -- --
05/04/2021 Q1 -- $1.5B $0.35 -- --
02/24/2021 Q4 -- $1.7B -$0.30 -- --
11/12/2020 Q3 -- $1.5B $0.17 -- --
08/05/2020 Q2 -- $1.6B -$0.08 -- --
05/04/2020 Q1 -- $1.2B $0.39 -- --
02/20/2020 Q4 -- $1.9B $0.57 -- --
11/06/2019 Q3 -- $1.6B $1.09 -- --
08/06/2019 Q2 -- $1.8B $1.20 -- --
05/23/2019 Q1 -- $1.8B $1.11 -- --
02/21/2019 Q4 -- $1.7B $1.32 -- --
11/07/2018 Q3 -- $1.7B $0.76 -- --
08/01/2018 Q2 -- $1.8B $0.87 -- --
05/16/2018 Q1 -- $1.8B $0.76 -- --
02/21/2018 Q4 -- $1.9B $1.26 -- --
10/26/2017 Q3 -- $1.8B $0.63 -- --
08/09/2017 Q2 -- $1.9B $0.93 -- --
05/24/2017 Q1 -- $1.9B $0.87 -- --
02/22/2017 Q4 -- $1.7B $1.56 -- --
11/22/2016 Q3 -- $1.8B $0.85 -- --
08/19/2016 Q2 -- $1.7B $1.02 -- --
05/23/2016 Q1 -- $1.5B $0.51 -- --
03/09/2016 Q4 -- $1.3B $0.89 -- --

Grupo Cibest SA Earnings Questions

  • How Much did Grupo Cibest SA Generate in Revenue Last Quarter?

    Grupo Cibest SA reported $2.8B worth of top line sales in its most recent quarter.

  • Did Grupo Cibest SA Beat Earnings Last Quarter?

    Grupo Cibest SA announced earnings per share of $1.19 which represents a miss of analyst forecast a $1.80 per share.

  • Is Grupo Cibest SA Profitable?

    Grupo Cibest SA reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Grupo Cibest SA EPS Next Year?

    Grupo Cibest SA's earnings are forecast to grow from $3.42 per share to $6.02 per share next year representing an increase of 128.12%.

  • When is Grupo Cibest SA's Earnings Date?

    Grupo Cibest SA's next earnings date is February 11, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock